A Randomized Clinical Trial of Topical Gentamicin After Tympanostomy Tube Placement
- 1 July 1988
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 114 (7) , 755-757
- https://doi.org/10.1001/archotol.1988.01860190059023
Abstract
• Purulent otorrhea is the most common complication of tympanostomy with tube placement. Some authors report an incidence of over 30%. We have evaluated topical gentamicin solution for prophylaxis in a controlled, randomized, prospective clinical trial. Nine patients of the 102 in the study developed otorrhea in the first two postoperative weeks. All nine were in the control group of 46. The 56 patients receiving prophylactic gentamicin had no cases of purulent otorrhea. Several other characteristics of the patients and the procedures were examined as possible risk factors for otorrhea. None were statistically significant, but the younger patients had a higher rate of infection. We recognize the theoretical risk of ototoxicity, but conclude that instillation of topical gentamicin is an effective prophylactic technique for preventing purulent otorrhea after tympanostomy. (Arch Otolaryngol Head Neck Surg 1988;114:755-757)This publication has 6 references indexed in Scilit:
- Compliance with Pediatric TherapyClinical Pediatrics, 1983
- Ototoxicity of propylene glycol in experimental animalsAmerican Journal of Otolaryngology, 1980
- AMINOGLYCOSIDE OTOTOXICITY IN THE HUMANThe Laryngoscope, 1980
- Secretory Otitis Media: Long-term Observations After Treatment With GrommetsJAMA Otolaryngology–Head & Neck Surgery, 1980
- Comparative Study of Various Ventilating TubesAnnals of Otology, Rhinology & Laryngology, 1976
- A Treatment for Chronic Serous Otitis Media in ChildrenPractica Oto-Rhino-Laryngologica, 1972